CN103272638B - Chiral guanidine catalyst based on tartaric acid skeleton and its preparation method and application - Google Patents
Chiral guanidine catalyst based on tartaric acid skeleton and its preparation method and application Download PDFInfo
- Publication number
- CN103272638B CN103272638B CN201310218970.4A CN201310218970A CN103272638B CN 103272638 B CN103272638 B CN 103272638B CN 201310218970 A CN201310218970 A CN 201310218970A CN 103272638 B CN103272638 B CN 103272638B
- Authority
- CN
- China
- Prior art keywords
- reaction
- chiral
- product
- guanidine catalyst
- chiral guanidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC1(C)OCC*1 Chemical compound CC1(C)OCC*1 0.000 description 3
- QAKRRZDTKNNJIL-ZALKHPQZSA-N C[C@@H]1C=C(C(C2CCCCC2)([C@@H]2OCC(C)(C)OC2CC(C2CCCCC2)(C2CCCCCC2)N)N)C=CC1 Chemical compound C[C@@H]1C=C(C(C2CCCCC2)([C@@H]2OCC(C)(C)OC2CC(C2CCCCC2)(C2CCCCCC2)N)N)C=CC1 QAKRRZDTKNNJIL-ZALKHPQZSA-N 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Cc1ccccc1 Chemical compound Cc1ccccc1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域 technical field
本发明涉及一种基于酒石酸骨架的手性胍催化剂及其制备方法,及其在催化β-二羰基化合物的不对称α-羟基化反应中的应用。属于催化剂技术及其制备方法领域。 The invention relates to a chiral guanidine catalyst based on a tartaric acid skeleton, a preparation method thereof, and an application thereof in catalyzing the asymmetric α-hydroxylation reaction of β-dicarbonyl compounds. The invention belongs to the field of catalyst technology and its preparation method.
背景技术 Background technique
手性(Chirality)是自然界的本质属性之一。作为生命活动重要基础的生物大分子,如蛋白质、多糖、核酸和酶等,几乎全是手性的,这些分子在体内往往具有重要生理功能。近年来,随着合成方法的发展,越来越多的手性化合物可通过化学合成法得到。不对称催化合成己成为获取手性物质的重要手段,是手性药物工业化生产必须突破的关键技术之一。用酶作为催化剂是人们所熟知的,它的高反应活性和高立体选择性一直是人们梦寐以求的目标。有机小分子催化剂已经被认为是继酶和手性金属络合物催化剂之后的第三类用途广泛的手性催化剂,在手性分子的合成中是一个较新且备受关注的领域。胍基官能团比较广泛地存在于各种天然分子中,由于胍基具有很强的碱性,能以碱的方式活化多种反应底物,因此,具有高活性和高选择性的手性胍催化剂作为有机催化剂的重要成员之一(其他有机小分子催化剂包括L-脯氨酸及其衍生物,金鸡纳碱及其衍生物,手性膦酸,手性硫脲,氮杂环卡宾等)已经被广泛地应用于不对称合成中。因此,发展新的手性胍催化剂并将其应用于不对称催化近年来备受关注。 Chirality is one of the essential properties of nature. Biomacromolecules, such as proteins, polysaccharides, nucleic acids and enzymes, which are the important basis of life activities, are almost all chiral, and these molecules often have important physiological functions in the body. In recent years, with the development of synthetic methods, more and more chiral compounds can be obtained by chemical synthesis. Asymmetric catalytic synthesis has become an important means of obtaining chiral substances, and is one of the key technologies that must be broken through in the industrial production of chiral drugs. The use of enzymes as catalysts is well known, and its high reactivity and high stereoselectivity have been long-awaited goals. Organosmall molecule catalysts have been considered as the third class of widely used chiral catalysts after enzymes and chiral metal complex catalysts, and are a relatively new and interesting field in the synthesis of chiral molecules. The guanidine functional group exists widely in various natural molecules. Due to the strong basicity of the guanidine group, it can be Alkali activates a variety of reaction substrates. Therefore, chiral guanidine catalysts with high activity and high selectivity are used as one of the important members of organic catalysts (other organic small molecule catalysts include L-proline and its derivatives, Jinji Sodium base and its derivatives, chiral phosphonic acid, chiral thiourea, azacyclic carbene, etc.) have been widely used in asymmetric synthesis. Therefore, the development of new chiral guanidine catalysts and their application in asymmetric catalysis have attracted much attention in recent years.
已报道的手性胍催化剂主要包括:氨基酸衍生五元双环手性胍催化剂(E.J.Corey Org.Lett.1999,1,157-160;C.H.Tan Tetrahedron Lett.2006,47,1007-1010)、氨基酸衍生五元单环手性胍催化剂(T.Ishikawa Chem.Commun.2001,245-246)、氨基酸衍生双硫脲链状胍盐(K.Nagasawa Adv.Synth.Catal.2005,347,1643-1648)、BINOL衍生单环手性胍催化剂(M.Terada J.Am.Chem.Soc.2006,128,16044-16045)、手性环己二胺衍生链状胍盐(E.N.Jacobsen J.Am.Chem.Soc.2008,130,9228-9229)、脯氨酸衍生双功能手性胍催化剂(X.M.Feng Angew.Chem.Int.Ed.2009,48,5195-5198)、丝氨酸衍双环双功能手性胍催化剂(T.Misaki and T.Sugimura J.Am.Chem.Soc.2010,132,6286-6287)。 The reported chiral guanidine catalysts mainly include: amino acid-derived five-membered bicyclic chiral guanidine catalysts (E.J.Corey Org. Monocyclic chiral guanidine catalyst (T.Ishikawa Chem.Commun.2001,245-246), amino acid derived dithiourea chain guanidine salt (K.Nagasawa Adv.Synth.Catal.2005,347,1643-1648), BINOL Derived monocyclic chiral guanidine catalyst (M.Terada J.Am.Chem.Soc.2006,128,16044-16045), chiral cyclohexanediamine derived chain guanidine salt (E.N.Jacobsen J.Am.Chem.Soc. 2008,130,9228-9229), proline-derived bifunctional chiral guanidine catalyst (X.M.Feng Angew.Chem.Int.Ed.2009,48,5195-5198), serine-derived bicyclic bifunctional chiral guanidine catalyst (T .Misaki and T.Sugimura J.Am.Chem.Soc.2010,132,6286-6287).
总体而言,虽然已经有很多手性胍催化剂被开发,但是手性胍的种类仍然有限,其催化性能还有待于充分的发掘。因此,开发结构新颖、具有高活性和高立体选择性的手性胍催化剂并将其应用于手性合成仍然是不对称有机合成领域的重要目标之一。 Overall, although many chiral guanidine catalysts have been developed, the types of chiral guanidines are still limited, and their catalytic properties have yet to be fully explored. Therefore, the development of chiral guanidine catalysts with novel structures, high activity and high stereoselectivity and their application in chiral synthesis is still one of the important goals in the field of asymmetric organic synthesis.
发明内容 Contents of the invention
本发明着眼于新型手性胍的设计合成及其在不对称催化上的应用。以廉价易得的酒石酸酯为原料,经过七步反应合成了一系列基于酒石酸骨架的新型手性胍催化剂;并且区别于文献中报道的先从硫脲合成异硫脲、进而合成手性胍催化剂的传统路线,本发明在氯化亚铜和碳酸钾的作用下由酒石酸衍生的硫脲与胺反应一步合成手性胍催化剂,并且反应条件温和(40℃),适用于多种胺(伯胺:烷基胺、苄胺、取代苄胺,苯胺、取代苯基胺、氨基醇;仲胺:环己胺)。 The invention focuses on the design and synthesis of novel chiral guanidine and its application in asymmetric catalysis. A series of new chiral guanidine catalysts based on tartaric acid skeleton were synthesized by seven-step reaction using cheap and easy-to-obtain tartrate esters as raw materials; and it was different from the synthesis of isothiourea from thiourea and then the synthesis of chiral guanidine catalysts reported in the literature According to the traditional route, the present invention reacts thiourea derived from tartaric acid with amine under the action of cuprous chloride and potassium carbonate to synthesize a chiral guanidine catalyst in one step, and the reaction conditions are mild (40°C), which is suitable for various amines (primary amines : Alkylamine, benzylamine, substituted benzylamine, aniline, substituted phenylamine, aminoalcohol; secondary amine: cyclohexylamine).
本发明的目的在于提供一种基于酒石酸骨架的手性胍催化剂,其为具有通式Ⅰ或Ⅱ的化合物: The object of the present invention is to provide a kind of chiral guanidine catalyst based on tartaric acid skeleton, it is the compound with general formula I or II:
Ⅰ I
Ⅱ II
其中, in,
R1为C1~C4烷基或苯基; R 1 is C 1 -C 4 alkyl or phenyl;
R2选自氢、C1-6烷基、芳香族基团、卤素、C1-6烷氧基和C1-6卤代烷基中的 一种; R 2 is selected from one of hydrogen, C 1-6 alkyl, aromatic group, halogen, C 1-6 alkoxy and C 1-6 haloalkyl;
R3为C1-6烷基、芳香族基团或氨基醇残链; R 3 is C 1-6 alkyl, aromatic group or aminoalcohol residual chain;
通式Ⅱ中,n=0、1或2。 In the general formula II, n=0, 1 or 2.
本发明所述手性胍催化剂的基本骨架七元环并五元环中分别含有胍基和缩酮结构单元;七元环上胍基的α,α’-位分别连有两个芳基基团。 The basic skeleton of the chiral guanidine catalyst of the present invention contains a seven-membered ring and a five-membered ring respectively containing guanidine and ketal structural units; the α and α'-positions of the guanidine group on the seven-membered ring are respectively connected with two aryl groups group.
本发明所述手性胍催化剂通式I和通式II中,R1为C1~C4烷基或苯基,优选为甲基。 In the general formula I and II of the chiral guanidine catalyst of the present invention, R 1 is C 1 -C 4 alkyl or phenyl, preferably methyl.
本发明所述手性胍催化剂通式I和通式II中,R2选自氢、C1-6烷基、芳香族基团、卤素、C1-6烷氧基和C1-6卤代烷基中的一种,优选为甲基、异丙基、叔丁基、苯基、4-位或3,5-位取代苯基、甲氧基或三氟甲基,进一步优选为氢或苯基。 In the general formula I and II of the chiral guanidine catalyst of the present invention, R is selected from hydrogen, C 1-6 alkyl, aromatic group, halogen, C 1-6 alkoxy and C 1-6 haloalkane One of the radicals, preferably methyl, isopropyl, tert-butyl, phenyl, 4- or 3,5-substituted phenyl, methoxy or trifluoromethyl, more preferably hydrogen or benzene base.
本发明所述手性胍催化剂通式I和通式II中,R2为任意取代的取代基。R2基团取代包括单取代和多取代,取代位包括苯基邻、间、对位的取代。 In the general formula I and general formula II of the chiral guanidine catalyst of the present invention, R 2 is an optionally substituted substituent. R 2 group substitution includes single substitution and multiple substitution, and the substitution position includes phenyl ortho, meta, para substitution.
本发明所述手性胍催化剂通式I和通式II中,R3为C1-6烷基、芳香族基团或氨基醇残链,优选为甲基、环己基、苯基、4-位或3,5-位取代苯基、苄基、4-位或3,4,5-位取代苄基,进一步优选为对甲基苄基、3,4,5-三甲氧基苄基,2,6-二异丙基苯基、3,5-二叔丁基苯基,L-叔亮氨醇或(1S,2S)-环己胺醇。 In the chiral guanidine catalyst general formula I and general formula II of the present invention, R is C 1-6 alkyl, aromatic group or aminoalcohol residual chain, preferably methyl, cyclohexyl, phenyl, 4- or 3,5-position substituted phenyl, benzyl, 4-position or 3,4,5-position substituted benzyl, more preferably p-methylbenzyl, 3,4,5-trimethoxybenzyl, 2,6-diisopropylphenyl, 3,5-di-tert-butylphenyl, L-tert-leucinol or (1S,2S)-cyclohexylamino alcohol.
本发明所述手性胍催化剂通式II中,n=0、1或2,优选n=1。 In the general formula II of the chiral guanidine catalyst of the present invention, n=0, 1 or 2, preferably n=1.
本发明所述手性胍催化剂通式I和通式II中,R2或R3基团所述4-位或3,5-位取代苯基或4-位、3,4,5-位取代苄基中,苯基或苄基上的取代基优选为甲基、异丙基、叔丁基、甲氧基、三氟甲基、氟和氯等。 In the general formula I and general formula II of the chiral guanidine catalyst described in the present invention, the 4-position or 3,5-position substituted phenyl or 4-position, 3,4,5-position of R2 or R3 group In the substituted benzyl group, the substituents on the phenyl group or benzyl group are preferably methyl group, isopropyl group, t-butyl group, methoxy group, trifluoromethyl group, fluorine, chlorine and the like.
本发明所述氨基醇残链指氨基酸还原得到的氨基醇中除去氨基以外的部分。例如,L-叔亮氨酸还原得到的L-叔亮氨醇,氨基酸残链为L-叔亮氨醇残链既1-叔丁基-2-羟基-乙基。 The aminoalcohol residual chain in the present invention refers to the part other than the amino group in the aminoalcohol obtained by reducing the amino acid. For example, L-tert-leucinol obtained by reduction of L-tert-leucine, the amino acid residue is L-tert-leucinol residue or 1-tert-butyl-2-hydroxyl-ethyl.
本发明所述手性胍催化剂典型化合物列于表1。表1中R2基团包括两种取代方式的指两种化合物,如4-Me、3,5-(Me)2指R2为4-Me或R2为3,5-(Me)2的两种化合物。 Typical compounds of the chiral guanidine catalyst of the present invention are listed in Table 1. In Table 1, the R 2 group includes two kinds of substitution means two compounds, such as 4-Me, 3,5-(Me) 2 means that R 2 is 4-Me or R 2 is 3,5-(Me) 2 of the two compounds.
表1结构通式(I、II)所示化合物结构 The structure of the compound shown in the general structural formula (I, II) of Table 1
表2化合物结构、物理性质与表征数据 Table 2 Compound structure, physical properties and characterization data
本发明所述手性胍催化剂优选选自下述编号1~12化合物的一种: The chiral guanidine catalyst of the present invention is preferably selected from one of the following numbered 1-12 compounds:
手性胍催化剂1:R1=CH3,R2=H,R3=(1S)-1-叔丁基-2-羟基乙基; Chiral guanidine catalyst 1: R 1 =CH 3 , R 2 =H, R 3 =(1S)-1-tert-butyl-2-hydroxyethyl;
手性胍催化剂2:R1=CH3,R2=H,R3=(1S,2S)-2-羟基环己基; Chiral guanidine catalyst 2: R 1 =CH 3 , R 2 =H, R 3 =(1S,2S)-2-hydroxycyclohexyl;
手性胍催化剂3:R1=CH3,R2=H,R3=2,6-二异丙基苯基; Chiral guanidine catalyst 3: R 1 =CH 3 , R 2 =H, R 3 =2,6-diisopropylphenyl;
手性胍催化剂4:R1=CH3,R2=H,R3=3,5-二叔丁基苯基; Chiral guanidine catalyst 4: R 1 =CH 3 , R 2 =H, R 3 =3,5-di-tert-butylphenyl;
手性胍催化剂5:R1=CH3,R2=H,R3=3,4,5-三甲氧基苄基; Chiral guanidine catalyst 5: R 1 =CH 3 , R 2 =H, R 3 =3,4,5-trimethoxybenzyl;
手性胍催化剂6:R1=CH3,R2=Ph,R3=对甲基苄基; Chiral guanidine catalyst 6: R 1 =CH 3 , R 2 =Ph, R 3 =p-methylbenzyl;
手性胍催化剂7:R1=CH3,R2=Ph,R3=(1S)-1-叔丁基-2-羟基乙基; Chiral guanidine catalyst 7: R 1 =CH 3 , R 2 =Ph, R 3 =(1S)-1-tert-butyl-2-hydroxyethyl;
手性胍催化剂8:R1=CH3,R2=Ph,R3=2,6-二异丙基苯基; Chiral guanidine catalyst 8: R 1 =CH 3 , R 2 =Ph, R 3 =2,6-diisopropylphenyl;
手性胍催化剂9:n=1,R2=H,R3=(1S)-1-叔丁基-2-羟基乙基; Chiral guanidine catalyst 9: n=1, R 2 =H, R 3 =(1S)-1-tert-butyl-2-hydroxyethyl;
手性胍催化剂10:n=1,R2=H,R3=3,5-二叔丁基苯基; Chiral guanidine catalyst 10: n=1, R 2 =H, R 3 =3,5-di-tert-butylphenyl;
手性胍催化剂11:n=1,R2=Ph,R3=(1S)-1-叔丁基-2-羟基乙基; Chiral guanidine catalyst 11: n=1, R 2 =Ph, R 3 =(1S)-1-tert-butyl-2-hydroxyethyl;
手性胍催化剂12:n=1,R2=Ph,R3=3,5-二叔丁基苯基; Chiral guanidine catalyst 12: n=1, R 2 =Ph, R 3 =3,5-di-tert-butylphenyl;
本发明的另一目的在于提供一种上述基于酒石酸骨架的手性胍催化剂的制备方法。 Another object of the present invention is to provide a method for preparing the above-mentioned chiral guanidine catalyst based on tartaric acid skeleton.
其中,通式I化合物的制备方法按下述工艺路线进行: Wherein, the preparation method of the compound of general formula I is carried out according to the following operational route:
通式II化合物的制备方法与通式I化合物制备方法工艺路线相同。 The preparation method of the compound of general formula II is the same as the process route of the preparation method of the compound of general formula I.
本发明所述方法中,通式II化合物按与通式I化合物相同工艺路线制备,按下述路线进行: In the method of the present invention, the compound of general formula II is prepared by the same process route as the compound of general formula I, and is carried out according to the following route:
包括以下步骤: Include the following steps:
①缩合反应:将酒石酸酯与酮或缩酮按摩尔比1:1~1:1.5在路易斯酸的催化 下,于苯或甲苯中回流反应12~24h;所得反应液加入碳酸氢钠、水处理、萃取、洗涤、干燥,最后浓缩得浓缩产物; ①Condensation reaction: The tartrate ester and ketone or ketal molar ratio 1:1~1:1.5 are catalyzed by Lewis acid, and reflux reaction in benzene or toluene for 12~24h; the obtained reaction solution is treated with sodium bicarbonate and water , extraction, washing, drying, and finally concentrating to obtain a concentrated product;
②格氏反应:将步骤①所得缩合产物与格氏试剂按摩尔比1:4.5~1:5在四氢呋喃中,于回流条件下反应30~90分钟;降温、淬灭、萃取、洗涤、干燥、浓缩,乙酸乙酯/石油醚重结晶得产物; ②Grignard reaction: react the condensation product obtained in step ① with the Grignard reagent in tetrahydrofuran at a molar ratio of 1:4.5 to 1:5 under reflux for 30 to 90 minutes; cool down, quench, extract, wash, dry, Concentrate and recrystallize from ethyl acetate/petroleum ether to obtain the product;
③氯化反应:将步骤②所得格氏反应产物溶于二氯甲烷中,与二氯亚砜、三乙胺按摩尔比1:3:4.2~1:3.5:7,在室温至回流温度下,反应3~12h;反应结束后,蒸出溶剂,得到氯化产物; ③ Chlorination reaction: Dissolve the Grignard reaction product obtained in step ② in dichloromethane, and thionyl chloride and triethylamine in a molar ratio of 1:3:4.2~1:3.5:7, at room temperature to reflux temperature , reacted for 3 to 12 hours; after the reaction was completed, the solvent was distilled off to obtain the chlorinated product;
④叠氮化反应:将步骤③所得氯化反应产物溶于N,N-二甲基甲酰胺中,与叠氮化钠按摩尔比1:4,于80℃反应72h;降温,反应液倒入水中,用乙醚萃取,有机层水洗、干燥、过滤,浓缩,快速柱层析得到固体,用乙醚/乙醇重结晶得产物; ④Azidation reaction: Dissolve the chlorination reaction product obtained in step ③ in N,N-dimethylformamide, and react with sodium azide at a molar ratio of 1:4 at 80°C for 72 hours; cool down and pour the reaction solution Pour into water, extract with ether, wash the organic layer with water, dry, filter, concentrate, and obtain a solid by flash column chromatography, and recrystallize with ether/ethanol to obtain the product;
⑤还原反应:将步骤④所得叠氮化产物溶于四氢呋喃中,与四氢铝锂按摩尔比1:6,于0℃反应1.5~6h;淬灭、萃取、洗涤、干燥、浓缩,乙醚/正己烷重结晶得产物; ⑤ Reduction reaction: Dissolve the azide product obtained in step ④ in tetrahydrofuran, and react with lithium tetrahydrogen at a molar ratio of 1:6 at 0°C for 1.5 to 6 hours; quench, extract, wash, dry, concentrate, diethyl ether/ The product was obtained by recrystallization from n-hexane;
⑥具有酒石酸骨架的手性硫脲的制备:将步骤⑤所得还原产物溶于吡啶中,与二硫化碳按摩尔比1:2,于60℃反应12~24h;降温,反应液倒入水中,用二氯甲烷萃取;有机层水洗、干燥、过滤,浓缩,二氯甲烷/正己烷重结晶得产物; ⑥Preparation of chiral thiourea with tartaric acid skeleton: dissolve the reduction product obtained in step ⑤ in pyridine, and react with carbon disulfide at a molar ratio of 1:2 at 60°C for 12 to 24 hours; cool down, pour the reaction solution into water, and use two Chloromethane extraction; the organic layer was washed with water, dried, filtered, concentrated, and recrystallized from dichloromethane/n-hexane to obtain the product;
⑦具有酒石酸骨架的手性胍催化剂的制备:将步骤⑥所得硫脲与胺、氯化亚铜、碳酸钾按摩尔比1:1.2:2:4~1:10:2.1:15加入四氢呋喃中,于40℃反应4~72h;降温,淬灭、萃取、过滤、洗涤、干燥、浓缩,柱层析得到固体产物。 ⑦ preparation of chiral guanidine catalyst with tartaric acid skeleton: thiourea obtained in step ⑥ and amine, cuprous chloride, potassium carbonate are added in tetrahydrofuran in a molar ratio of 1:1.2:2:4~1:10:2.1:15, React at 40°C for 4-72 hours; cool down, quench, extract, filter, wash, dry, concentrate, and column chromatography to obtain a solid product.
本发明的又一目的是提供上述手性胍催化剂在催化β-二羰基化合物的不对称α-羟基化反应中的应用。 Another object of the present invention is to provide the application of the above-mentioned chiral guanidine catalyst in catalyzing the asymmetric α-hydroxylation reaction of β-dicarbonyl compounds.
一种β-二羰基化合物的不对称α-羟基化反应,包括下述步骤: Asymmetric α-hydroxylation reaction of a β-dicarbonyl compound, comprising the steps of:
氮气氛下,将β-二羰基化合物和上述手性胍催化剂按摩尔比1:0.1~1:0.01溶于甲苯中。冷却到-78℃。加入氧化剂(氧化剂与β-二羰基化合物的摩尔比为1.2:1)。-78℃反应。石油醚与乙酸乙酯为洗脱剂,柱层析分离得到不对称α-羟基化反应产物。 Under a nitrogen atmosphere, the β-dicarbonyl compound and the above-mentioned chiral guanidine catalyst are dissolved in toluene at a molar ratio of 1:0.1 to 1:0.01. Cool to -78°C. Add the oxidizing agent (the molar ratio of oxidizing agent to β-dicarbonyl compound is 1.2:1). Reaction at -78°C. Petroleum ether and ethyl acetate were used as eluents, and the asymmetric α-hydroxylation reaction product was obtained by column chromatography.
β-二羰基化合物包括:茚酮衍生β-酮酸酯和β-二酮,四氢萘酮衍生β-酮酸酯和β-二酮等。 β-dicarbonyl compounds include: β-ketoesters and β-diketones derived from indanone, β-ketoesters and β-diketones derived from tetralone, etc.
除另有说明外,本文中使用的术语具有以下含义。 Unless otherwise specified, the terms used herein have the following meanings.
本文中使用的术语“烷基”包括直链烷基和支链烷基。如提及单个烷基如“丙基”,则只特指直链烷基,如提及单个支链烷基如“异丙基”,则只特指支链烷基。例如,“C1-6烷基”包括C1-4烷基、C1-3烷基、甲基、乙基、正丙基、异丙基和叔丁基。类似的规则也适用于本说明书中使用的其它基团。 The term "alkyl" as used herein includes straight chain alkyl groups and branched chain alkyl groups. If a single alkyl group such as "propyl" is mentioned, it only refers to a straight chain alkyl group, and if a single branched chain alkyl group such as "isopropyl" is mentioned, it only refers to a branched chain alkyl group. For example, "C 1-6 alkyl" includes C 1-4 alkyl, C 1-3 alkyl, methyl, ethyl, n-propyl, isopropyl and tert-butyl. Similar rules apply to other groups used in this specification.
本文中使用的术语“卤素”包括氟、氯、溴和碘。 The term "halogen" as used herein includes fluorine, chlorine, bromine and iodine.
本发明的有益效果为:1)合成一系列基于酒石酸骨架的新型手性胍催化剂;2)发展了用于手性胍催化剂制备的新方法;3)将制备的基于酒石酸骨架的新型手性胍催化剂应用于β-二羰基化合物的不对称α-羟基化反应,取得几乎定量的收率和非常好的对映选择性,为合成光学活性的α-羟基-β-二羰基化合物提供了重要的不对称有机催化方法。 The beneficial effects of the present invention are: 1) synthesis of a series of new chiral guanidine catalysts based on tartaric acid skeleton; 2) development of a new method for the preparation of chiral guanidine catalysts; 3) new chiral guanidine based on tartaric acid skeleton to be prepared The catalyst is applied to the asymmetric α-hydroxylation reaction of β-dicarbonyl compounds to obtain almost quantitative yield and very good enantioselectivity, which provides an important basis for the synthesis of optically active α-hydroxy-β-dicarbonyl compounds. Asymmetric organocatalytic approaches.
具体实施方式 Detailed ways
下面的实施例可以使本领域的普通技术人员更全面地理解本发明,但不以任何方式限制本发明。 The following examples can enable those skilled in the art to understand the present invention more fully, but do not limit the present invention in any way.
实施例1: Example 1:
反应试剂与条件:a)2,2-二甲氧基丙烷,对甲苯磺酸,苯,回流,12h;b)溴苯,镁粉,四氢呋喃,回流,1.5h,产率91%(两步反应);c)二氯亚砜,三乙胺,二氯甲烷,回流,3h,产率65%;d)叠氮钠,N,N-二甲基甲酰胺,80℃,72h,产率77%;e)四氢铝锂,四氢呋喃,0℃,4h,产率93%;f)二硫化碳,吡啶,60℃,产率98%;g)取代胺,氯化亚铜,碳酸钾,四氢呋喃,40℃,4-30h,产率87-95%。 Reagents and conditions: a) 2,2-dimethoxypropane, p-toluenesulfonic acid, benzene, reflux, 12h; b) bromobenzene, magnesium powder, tetrahydrofuran, reflux, 1.5h, yield 91% (two steps reaction); c) thionyl chloride, triethylamine, dichloromethane, reflux, 3h, yield 65%; d) sodium azide, N,N-dimethylformamide, 80°C, 72h, yield 77%; e) lithium aluminum tetrahydrogen, tetrahydrofuran, 0 ℃, 4h, yield 93%; f) carbon disulfide, pyridine, 60 ℃, yield 98%; g) substituted amine, cuprous chloride, potassium carbonate, tetrahydrofuran , 40°C, 4-30h, yield 87-95%.
1.G1-1的合成: 1. Synthesis of G1-1:
氮气氛下,向250mL三口烧瓶中,依次加入无水苯(148mL)、L-酒石酸二乙酯(12.4g,60mmol)、2,2-二甲氧基丙烷(9.4g,11mL,90mmol,1.5eq.)、对甲苯磺酸(0.12g)。升温至回流,反应12h。冷却到室温,加入NaHCO3(1.5 g)继续搅拌30min。加入水(100mL),分出有机相,水相用乙酸乙酯萃取两次(60mL×2),合并有机相,水洗(50mL×1),饱和氯化钠水溶液洗(50mL×1),无水硫酸钠干燥,蒸出溶剂得缩酮为黄色油状物14.8g,产率100%。 Under nitrogen atmosphere, add anhydrous benzene (148mL), L-diethyl tartrate (12.4g, 60mmol), 2,2-dimethoxypropane (9.4g, 11mL, 90mmol, 1.5 eq.), p-toluenesulfonic acid (0.12g). Warm up to reflux and react for 12h. After cooling to room temperature, NaHCO 3 (1.5 g) was added and stirring was continued for 30 min. Add water (100mL), separate the organic phase, extract the aqueous phase twice with ethyl acetate (60mL×2), combine the organic phases, wash with water (50mL×1), and wash with saturated sodium chloride aqueous solution (50mL×1). Dry over sodium sulfate, and distill off the solvent to obtain 14.8 g of the ketal as a yellow oil, with a yield of 100%.
氮气氛下,将装有新制格氏试剂{由溴苯47.1g(300mmol,5.0eq.),镁粉8.0g(330mmol,5.5eq.)和四氢呋喃(180mL)制得}的250mL三口烧瓶置于冰水浴中,缓慢滴加溶有上述所得缩酮(14.8g,60mmol,1.0eq.)的四氢呋喃(15mL)溶液。加完升温至回流,反应1.5h。冷却到室温,加入饱和氯化铵水溶液(400mL)淬灭反应。分出有机相,水相用乙酸乙酯萃取(300mL×1、100mL×2),合并有机相,水洗(100mL×1),饱和氯化钠水溶液洗(100mL×1),无水硫酸钠干燥,蒸出溶剂,乙酸乙酯/石油醚重结晶得白色固体G1-125.6g,产率91%。1H NMR(400MHz,CDCl3/TMS):δ7.52(dd,J=7.8,1.3Hz,4H),7.33-7.22(m,16H),4.59(s,2H),3.92(s,2H),1.03(s,6H)。 Under a nitrogen atmosphere, place a 250mL three-neck flask containing a newly prepared Grignard reagent {made from 47.1g (300mmol, 5.0eq.) of bromobenzene, 8.0g (330mmol, 5.5eq.) of magnesium powder and tetrahydrofuran (180mL)} into In an ice-water bath, a solution of tetrahydrofuran (15 mL) dissolved with the above obtained ketal (14.8 g, 60 mmol, 1.0 eq.) was slowly added dropwise. After the addition, the temperature was raised to reflux, and the reaction was carried out for 1.5h. After cooling to room temperature, saturated aqueous ammonium chloride solution (400 mL) was added to quench the reaction. Separate the organic phase, extract the aqueous phase with ethyl acetate (300mL×1, 100mL×2), combine the organic phases, wash with water (100mL×1), wash with saturated sodium chloride aqueous solution (100mL×1), and dry over anhydrous sodium sulfate , evaporated the solvent, and recrystallized from ethyl acetate/petroleum ether to obtain a white solid G1-125.6g, yield 91%. 1 H NMR (400MHz, CDCl 3 /TMS): δ7.52(dd,J=7.8,1.3Hz,4H),7.33-7.22(m,16H),4.59(s,2H),3.92(s,2H) ,1.03(s,6H).
2.G1-2的合成: 2. Synthesis of G1-2:
氮气氛下,向溶有G1-1(4.7g,10mmol,1.0eq.)的二氯甲烷(60mL)溶液的250mL三口烧瓶中,滴加氯化亚砜(1.8g,30mmol,3.0eq.)。将反应液升温至回流,缓慢滴加溶有三乙胺(4.2g,42mmol,4.2eq.)的二氯甲烷(60mL)溶液,TLC检测反应。反应完全后冷却到室温,将反应液倾入冷的饱和碳酸氢钠(200mL)溶液中,搅拌2h。分出有机相,水相二氯甲烷取(100mL×1),合并有机相,饱和氯化钠水溶液洗(100mL×1),无水硫酸钠干燥,蒸出溶剂快速柱层析(石油醚/乙醚=10/1)得褐色固体。粗产物二氯甲烷/石油醚重结晶得白色固体G1-23.3g,产率65%。1H NMR(400MHz,CDCl3/TMS):δ7.48-7.41(m,8H),7.33-7.16(m,12H),5.45(s,2H),0.97(s,6H)。 Under a nitrogen atmosphere, add thionyl chloride (1.8g, 30mmol, 3.0eq.) dropwise to a 250mL three-necked flask containing a solution of G1-1 (4.7g, 10mmol, 1.0eq.) in dichloromethane (60mL) . The temperature of the reaction solution was raised to reflux, and a solution of triethylamine (4.2g, 42mmol, 4.2eq.) in dichloromethane (60mL) was slowly added dropwise, and the reaction was detected by TLC. After the reaction was complete, it was cooled to room temperature, and the reaction solution was poured into cold saturated sodium bicarbonate (200 mL) solution, and stirred for 2 h. Separate the organic phase, take the aqueous phase as dichloromethane (100mL×1), combine the organic phases, wash with saturated sodium chloride aqueous solution (100mL×1), dry over anhydrous sodium sulfate, evaporate the solvent and flash column chromatography (petroleum ether/ Diethyl ether = 10/1) to obtain a brown solid. The crude product was recrystallized from dichloromethane/petroleum ether to obtain a white solid G1-23.3g with a yield of 65%. 1 H NMR (400MHz, CDCl 3 /TMS): δ7.48-7.41 (m, 8H), 7.33-7.16 (m, 12H), 5.45 (s, 2H), 0.97 (s, 6H).
3.G1-3的合成: 3. Synthesis of G1-3:
氮气氛下,向溶有G1-2(2.5g,5mmol,1.0eq.)的N,N-二甲基甲酰胺(15mL)溶液的50mL三口烧瓶中,加入叠氮化钠(1.3g,20mmol,4.0eq.)。将反应液升温至80℃,反应72h。反应完全后冷却到室温,将反应液倾入冷的水(100mL)中,分出有机相,水相乙醚取三次(50mL×3)。合并有机相,水洗三次(35mL×3),无水硫酸钠干燥,蒸出溶剂,粗产物乙醚/乙醇重结晶得白色固体G1-32.0g,产率77%。1H NMR(400MHz,CDCl3/TMS):δ7.34-7.24(m,10H),4.92(s,2H),1.11(s,6H)。 Under nitrogen atmosphere, add sodium azide (1.3g, 20mmol ,4.0eq.). The temperature of the reaction solution was raised to 80°C, and the reaction was carried out for 72h. After the reaction was complete, cool to room temperature, pour the reaction solution into cold water (100 mL), separate the organic phase, and take the aqueous phase ether three times (50 mL×3). The organic phases were combined, washed three times with water (35mL×3), dried over anhydrous sodium sulfate, and the solvent was distilled off. The crude product was recrystallized in ether/ethanol to obtain a white solid G1-32.0g, with a yield of 77%. 1 H NMR (400 MHz, CDCl 3 /TMS): δ 7.34-7.24 (m, 10H), 4.92 (s, 2H), 1.11 (s, 6H).
4.G1-4的合成: 4. Synthesis of G1-4:
氮气氛下,将LiAlH4(1.6g,42mmol,6.0eq.)悬浮于四氢呋喃(40mL) 中,冷却到0℃。缓慢滴加溶有G1-3(3.6g,7mmol,1.0eq.)的四氢呋喃(40mL)溶液。0℃反应4h。反应完全后,1M NaOH(5mL)淬灭反应。反应液加乙醚(20mL)稀释后,加入无水硫酸钠(20g),室温搅拌2h。滤除固体,无水碳酸钾干燥,蒸出溶剂,粗产物乙醚/正己烷重结晶得白色固体G1-43.0g,产率93%。1H NMR(400MHz,CDCl3/TMS):δ7.55-7.53(m,4H),7.36-7.29(m,6H),7.20-7.13(m,10H),4.92(s,2H),2.30(brs,4H),1.11(s,6H)。 Under nitrogen atmosphere, LiAlH4 (1.6g, 42mmol, 6.0eq.) was suspended in tetrahydrofuran (40mL) and cooled to 0°C. A solution of G1-3 (3.6g, 7mmol, 1.0eq.) in tetrahydrofuran (40mL) was slowly added dropwise. 0 ℃ reaction 4h. After the reaction was complete, the reaction was quenched with 1M NaOH (5 mL). After diluting the reaction solution with diethyl ether (20 mL), anhydrous sodium sulfate (20 g) was added and stirred at room temperature for 2 h. The solid was filtered off, dried with anhydrous potassium carbonate, and the solvent was distilled off. The crude product was recrystallized in ether/n-hexane to obtain a white solid G1-43.0 g, with a yield of 93%. 1 H NMR (400MHz, CDCl 3 /TMS): δ7.55-7.53 (m, 4H), 7.36-7.29 (m, 6H), 7.20-7.13 (m, 10H), 4.92 (s, 2H), 2.30 ( brs,4H), 1.11(s,6H).
5.G1-5的合成: 5. Synthesis of G1-5:
氮气氛下,向溶有G1-4(1.393g,3mmol,1.0eq.)的吡啶(5mL)溶液中加入二硫化碳(361μL,6mmol,2.0eq.)。将反应液升温至60℃,反应18h。反应完全后冷却到室温,向反应液中加二氯甲烷(20mL)和水(10mL),1M HCl调pH=2,分出有机相,水相二氯甲烷取三次(50mL×3),合并有机相,1M NaOH溶液洗(50mL×1),饱和氯化钠溶液洗(60mL×1),无水硫酸钠干燥,蒸出溶剂,粗产物二氯甲烷/正己烷重结晶得白色固体G1-51.489g,产率98%。Mp277.4-278.6℃;[α]D 24=-191.3(c0.31,CH2Cl2);1H NMR(400MHz,CDCl3/TMS):δ7.63-7.61(m,4H),7.44-7.39(m,6H),7.28(m,6H),7.15(m,4H),6.85(s,2H),4.59(s,2H),1.20(s,6H);13C NMR(101MHz,CDCl3/TMS):δ185.9,143.4,139.6,129.3,128.8,128.5,128.1,128.0,127.7,110.8,78.0,70.5,26.9;IR(KBr):3386,3062,2983,2904,1515,1495,1457,1444,1164,1105,755,698,681;HRMS(ESI)Calcd.for C32H30N2O2NaS+([M+Na]+)529.1926,Found529.1921。 Under a nitrogen atmosphere, carbon disulfide (361 μL, 6 mmol, 2.0 eq.) was added to a solution of G1-4 (1.393 g, 3 mmol, 1.0 eq.) in pyridine (5 mL). The temperature of the reaction solution was raised to 60° C., and the reaction was carried out for 18 hours. After the reaction is complete, cool to room temperature, add dichloromethane (20mL) and water (10mL) to the reaction solution, adjust the pH to 2 with 1M HCl, separate the organic phase, and take three times (50mL×3) of the aqueous phase dichloromethane, and combine Organic phase, washed with 1M NaOH solution (50mL×1), washed with saturated sodium chloride solution (60mL×1), dried over anhydrous sodium sulfate, evaporated the solvent, and recrystallized the crude product from dichloromethane/n-hexane to obtain a white solid G1- 51.489g, yield 98%. Mp277.4-278.6℃;[α] D 24 =-191.3(c0.31,CH 2 Cl 2 ); 1 H NMR(400MHz,CDCl 3 /TMS):δ7.63-7.61(m,4H),7.44 -7.39(m,6H),7.28(m,6H),7.15(m,4H),6.85(s,2H),4.59(s,2H),1.20(s,6H); 13 C NMR(101MHz,CDCl 3 /TMS): δ185.9, 143.4, 139.6, 129.3, 128.8, 128.5, 128.1, 128.0, 127.7, 110.8, 78.0, 70.5, 26.9; IR(KBr): 3386, 3062, 2983, 2904, 1515, 1495, 1457, 1444, 1164, 1105, 755, 698, 681; HRMS (ESI) Calcd. for C 32 H 30 N 2 O 2 NaS + ([M+Na] + ) 529.1926, Found 529.1921.
5.手性胍的合成: 5. Synthesis of chiral guanidine:
1)手性胍2的合成: 1) Synthesis of chiral guanidine 2:
氮气氛下,向50mL反应瓶中依次加入无水碳酸钾(165.9mg,1.2mmol,6.0eq.)、氯化亚铜(41.6mg,0.42mmol,2.1eq.)、四氢呋喃(2mL)、G1-5(101.3mg,0.2mmol,1.0eq.)。室温搅拌10min后,加入1S,2S,-环己胺醇盐酸盐(60.7mg,0.4mmol,2.0eq.),升温至40℃,反应30h。反应完全后冷却到室温,向反应液中加饱和氯化铵溶液(30mL),1M HCl调pH=4,二氯甲烷取三次(30mL×3),合并有机相过滤,滤液饱和氯化钠溶液洗(20mL×1),无水硫酸钠干燥,蒸出溶剂,粗产物柱层析(二氯甲烷/甲醇=50/1)得白色固体。将所得固体溶于二氯甲烷(25mL)中,加入2M NaOH溶液(5mL),室温搅拌2h。水相二氯甲烷取(5mL×2),合并有机相,饱和氯化钠溶液洗(10mL×1),无水碳酸钾干燥,蒸出溶剂得白色固体2102.3mg,产率87%。 Under nitrogen atmosphere, add anhydrous potassium carbonate (165.9mg, 1.2mmol, 6.0eq.), cuprous chloride (41.6mg, 0.42mmol, 2.1eq.), tetrahydrofuran (2mL), G1- 5 (101.3 mg, 0.2 mmol, 1.0 eq.). After stirring at room temperature for 10 min, 1S,2S,-cyclohexylaminoalcohol hydrochloride (60.7mg, 0.4mmol, 2.0eq.) was added, the temperature was raised to 40°C, and the reaction was carried out for 30h. After the reaction is complete, cool to room temperature, add saturated ammonium chloride solution (30mL) to the reaction solution, adjust the pH to 4 with 1M HCl, take three times of dichloromethane (30mL×3), combine the organic phases and filter, and the filtrate is saturated with sodium chloride solution Wash (20mL×1), dry over anhydrous sodium sulfate, evaporate the solvent, and column chromatography (dichloromethane/methanol=50/1) of the crude product gives a white solid. The obtained solid was dissolved in dichloromethane (25 mL), added with 2M NaOH solution (5 mL), and stirred at room temperature for 2 h. The aqueous phase dichloromethane was taken (5 mL×2), the organic phases were combined, washed with saturated sodium chloride solution (10 mL×1), dried with anhydrous potassium carbonate, and the solvent was distilled off to obtain 2102.3 mg of a white solid, with a yield of 87%.
2)手性胍13的合成: 2) Synthesis of chiral guanidine 13:
氮气氛下,向50mL反应瓶中依次加入无水碳酸钾(276.4mg,2.0mmol,4.0eq.)、氯化亚铜(104.0mg,1.05mmol,2.1eq.)、四氢呋喃(5mL)、G1-5(235.3mg,0.5mmol,1.0eq.),室温搅拌10min后,加入(S)-苯乙胺(72.7mg,76.5μL,0.6mmol,1.2eq.)。升温至40℃,反应4h。反应完全后冷却到室温,向反应液中加饱和氯化铵溶液(30mL),1M HCl调pH=4,二氯甲烷取三次(30mL×3),合并有机相过滤,滤液饱和氯化钠溶液洗(20mL×1),无水硫酸钠干燥,蒸出溶剂,粗产物柱层析(二氯甲烷/甲醇=50/1)得白色固体。将所得固体溶于二氯甲烷(30mL)中,加入2M NaOH溶液(5mL),室温搅拌2h,水相二氯甲烷取(5mL×2),合并有机相,饱和氯化钠溶液洗(10mL×1),无水碳酸钾干燥,蒸出溶剂得白色固体13282.3mg,产率95%。 Under nitrogen atmosphere, add anhydrous potassium carbonate (276.4mg, 2.0mmol, 4.0eq.), cuprous chloride (104.0mg, 1.05mmol, 2.1eq.), tetrahydrofuran (5mL), G1- 5 (235.3mg, 0.5mmol, 1.0eq.), after stirring at room temperature for 10min, (S)-phenylethylamine (72.7mg, 76.5μL, 0.6mmol, 1.2eq.) was added. Raise the temperature to 40°C and react for 4h. After the reaction is complete, cool to room temperature, add saturated ammonium chloride solution (30mL) to the reaction solution, adjust the pH to 4 with 1M HCl, take three times of dichloromethane (30mL×3), combine the organic phases and filter, and the filtrate is saturated with sodium chloride solution Wash (20mL×1), dry over anhydrous sodium sulfate, evaporate the solvent, and column chromatography (dichloromethane/methanol=50/1) of the crude product gives a white solid. Dissolve the obtained solid in dichloromethane (30mL), add 2M NaOH solution (5mL), stir at room temperature for 2h, take the aqueous phase in dichloromethane (5mL×2), combine the organic phases, and wash with saturated sodium chloride solution (10mL×2) 1), dried with anhydrous potassium carbonate, and distilled off the solvent to obtain 13282.3 mg of white solid, with a yield of 95%.
实施例2: Example 2:
反应试剂与条件:a)2,2-二甲氧基丙烷,对甲苯磺酸,苯,回流,12h;b)4-苯基溴苯,镁粉,四氢呋喃,回流,1.5h,产率95%(两步反应);c)二氯亚砜,三乙胺,二氯甲烷,回流,3h;d)叠氮钠,N,N-二甲基甲酰胺,80℃,72h,产率79%(两步反应);e)四氢铝锂,四氢呋喃,0℃,4h,产率84%;f)二硫化碳,吡啶,60℃,产率99%;g)取代胺,氯化亚铜,碳酸钾,四氢呋喃,40℃,15-48h,产率71-85%。 Reagents and conditions: a) 2,2-dimethoxypropane, p-toluenesulfonic acid, benzene, reflux, 12h; b) 4-phenylbromobenzene, magnesium powder, tetrahydrofuran, reflux, 1.5h, yield 95 % (two-step reaction); c) thionyl chloride, triethylamine, dichloromethane, reflux, 3h; d) sodium azide, N,N-dimethylformamide, 80 ° C, 72h, yield 79 % (two-step reaction); e) lithium aluminum tetrahydrogen, tetrahydrofuran, 0 ℃, 4h, yield 84%; f) carbon disulfide, pyridine, 60 ℃, yield 99%; g) substituted amine, cuprous chloride, Potassium carbonate, tetrahydrofuran, 40°C, 15-48h, yield 71-85%.
1.G2-1的合成: 1. Synthesis of G2-1:
氮气氛下,向250mL三口烧瓶中依次加入无水苯(148mL)、L-酒石酸二乙酯(4.1g,20mmol)、2,2-二甲氧基丙烷(3.1g,3.7mL,30mmol,1.5eq.)、对甲苯磺酸(0.03g)。升温至回流,反应12h。冷却到室温,加入NaHCO3(0.5g)继续搅拌30min。加入水(40mL),分出有机相,水相乙酸乙酯萃取两次(30mL×2),合并有机相,水洗(30mL×1),饱和氯化钠水溶液洗(30mL×1),无 水硫酸钠干燥,蒸出溶剂得缩酮为黄色油状物4.9g,产率100%。 Under nitrogen atmosphere, add anhydrous benzene (148mL), L-diethyl tartrate (4.1g, 20mmol), 2,2-dimethoxypropane (3.1g, 3.7mL, 30mmol, 1.5 eq.), p-toluenesulfonic acid (0.03g). Warm up to reflux and react for 12h. After cooling to room temperature, NaHCO 3 (0.5 g) was added and stirring was continued for 30 min. Add water (40mL), separate the organic phase, extract the aqueous phase with ethyl acetate twice (30mL×2), combine the organic phases, wash with water (30mL×1), wash with saturated sodium chloride aqueous solution (30mL×1), anhydrous Dry over sodium sulfate, and distill off the solvent to obtain 4.9 g of the ketal as a yellow oil, with a yield of 100%.
氮气氛下,将装有新制格式试剂{由对溴联苯(22.4g,96mmol,4.8eq.);镁粉(2.6g,106mmol,5.3eq.)和四氢呋喃(85mL)制得}的250mL三口烧瓶置于冰水浴中。缓慢滴加溶有上述所得缩酮(4.9g,20mmol,1.0eq.)的四氢呋喃(10mL)溶液。加完升温至回流,反应1.5h。冷却到室温,加入饱和氯化铵水溶液(100mL)淬灭反应。分出有机相,水相乙酸乙酯萃取三次(150mL萃取1次,100mL萃取2次,表示为150mL×1、100mL×2,下同),合并有机相,水洗(80mL×1),饱和氯化钠水溶液洗(100mL×1),无水硫酸钠干燥,蒸出溶剂乙酸乙酯/石油醚重结晶得白色固体G2-114.6g,产率95%。1H NMR(400MHz,CDCl3/TMS):δ7.67-7.56(m,12H),7.53-7.29(m,24H),4.72(s,2H),4.23(brs,1H),1.16(s,3H)。 Under nitrogen atmosphere, put the newly prepared Grignard reagent {from p-bromobiphenyl (22.4g, 96mmol, 4.8eq.); The flask was placed in an ice water bath. A solution of tetrahydrofuran (10 mL) dissolved in the above obtained ketal (4.9 g, 20 mmol, 1.0 eq.) was slowly added dropwise. After the addition, the temperature was raised to reflux, and the reaction was carried out for 1.5h. After cooling to room temperature, saturated aqueous ammonium chloride solution (100 mL) was added to quench the reaction. Separate the organic phase, extract the aqueous phase with ethyl acetate three times (150mL extraction once, 100mL extraction twice, expressed as 150mL×1, 100mL×2, the same below), combine the organic phases, wash with water (80mL×1), saturated chlorine Wash with sodium chloride aqueous solution (100mL×1), dry over anhydrous sodium sulfate, distill off the solvent ethyl acetate/petroleum ether and recrystallize to obtain white solid G2-114.6g, yield 95%. 1 H NMR (400MHz, CDCl 3 /TMS): δ7.67-7.56(m,12H),7.53-7.29(m,24H),4.72(s,2H),4.23(brs,1H),1.16(s, 3H).
2.G2-2的合成: 2. Synthesis of G2-2:
氮气氛下,向溶有G2-1(1.54g,2mmol,1.0eq.)的二氯甲烷(15mL)溶液的100mL三口烧瓶中,滴加氯化亚砜(0.71g,3mmol,3.0eq.)。将反应液升温至回流,缓慢滴加溶有三乙胺(0.85g,8.4mmol,4.2eq.)的二氯甲烷(20mL)溶液,TLC检测反应。反应完全后冷却到室温,蒸出溶剂得黑褐色固体。加入N,N-二甲基甲酰胺(15mL),和叠氮化钠(0.52g,8mmol,4.0eq.)。加入将反应液升温至80℃,反应72h。反应完全后冷却到室温,将反应液倾入冷水(100mL)中,分出有机相,水相乙醚萃取三次(50mL×3)。合并有机相,水洗(35mL×3),无水硫酸钠干燥,蒸出溶剂,粗产物乙醚/乙醇重结晶得白色固体G2-21.29g,产率79%。Mp142.1-143.9℃;[α]D 24=-38.162(c0.36,CH2Cl2);1H NMR(400MHz,CDCl3/TMS):δ7.65-7.54(m,16H),7.47-7.31(m,20H),5.08(s,2H),1.25(s,6H);13C NMR(101MHz,CDCl3/TMS)δ140.7,140.5,140.5,140.4,139.2,130.0,128.9,128.8,128.7,127.6,127.4,127.1,127.1,126.8,126.4,110.8,80.8,73.0,27.6;IR(KBr):3061,3025,2986,2936,2106,1493,1447,1382,1372,1255,1216,1167,1070,978,764,745,703;Calcd.for C55H44N6O2Na+([M+Na]+)843.3423,Found843.3452。 Under a nitrogen atmosphere, add thionyl chloride (0.71g, 3mmol, 3.0eq.) dropwise to a 100mL three-necked flask containing a solution of G2-1 (1.54g, 2mmol, 1.0eq.) in dichloromethane (15mL) . The temperature of the reaction solution was raised to reflux, and a solution of triethylamine (0.85g, 8.4mmol, 4.2eq.) in dichloromethane (20mL) was slowly added dropwise, and the reaction was detected by TLC. After the reaction was complete, it was cooled to room temperature, and the solvent was distilled off to obtain a dark brown solid. N,N-Dimethylformamide (15 mL), and sodium azide (0.52 g, 8 mmol, 4.0 eq.) were added. After adding, the temperature of the reaction solution was raised to 80°C, and the reaction was carried out for 72h. After the reaction was complete, cool to room temperature, pour the reaction solution into cold water (100 mL), separate the organic phase, and extract the aqueous phase with ether three times (50 mL×3). The organic phases were combined, washed with water (35mL×3), dried over anhydrous sodium sulfate, and the solvent was distilled off. The crude product was recrystallized in ether/ethanol to obtain a white solid G2-21.29g, with a yield of 79%. Mp142.1-143.9℃;[α] D 24 =-38.162(c0.36,CH 2 Cl 2 ); 1 H NMR(400MHz,CDCl 3 /TMS):δ7.65-7.54(m,16H),7.47 -7.31(m,20H),5.08(s,2H),1.25(s,6H); 13 C NMR(101MHz,CDCl 3 /TMS)δ140.7,140.5,140.5,140.4,139.2,130.0,128.9,128.8,128.7 ,127.6,127.4,127.1,127.1,126.8,126.4,110.8,80.8,73.0,27.6; 1070,978,764,745,703; Calcd. for C 55 H 44 N 6 O 2 Na + ([M+Na] + ) 843.3423, Found 843.3452.
3.G2-3的合成: 3. Synthesis of G2-3:
氮气氛下,将LiAlH4(173.1mg,4.6mmol,6.0eq.)悬浮于四氢呋喃(8mL)中,冷却到0℃。缓慢滴加溶有G2-2(626.7mg,0.76mmol,1.0eq.)的四氢呋喃(8mL)溶液。0℃反应4h。反应完全后,1M NaOH(2mL)淬灭反应,反应液加乙醚(10mL)稀释后,加入无水硫酸钠(4g),室温搅拌2h。滤除固 体,无水碳酸钾干燥,蒸出溶剂,粗产物乙醚/正己烷重结晶得白色固体G2-3493.1mg,产率84%。Mp276.1-277.7℃;[α]D 24=-28.4(c0.34,CH2Cl2);1H NMR(400MHz,CDCl3/TMS):δ7.71-7.25(m,36H),4.39(s,2H),2.46(brs,4H),1.20(s,6H);13C NMR(101MHz,CDCl3/TMS):δ148.9,142.9,140.7,140.7,139.6,139.3,129.7,128.9,128.7,127.9,127.4,127.2,127.0,126.8,126.0,107.7,81.9,62.4,27.3;IR(KBr):3365,3166,3054,3026,2979,2869,1599,1486,1378,1369,1235,1219,1171,1072,1007,844,833,766,745,698;HRMS(ESI)Calcd.for C55H49N2O2 +([M+H]+)769.3794,Found769.3782。 Under nitrogen atmosphere, LiAlH 4 (173.1mg, 4.6mmol, 6.0eq.) was suspended in tetrahydrofuran (8mL) and cooled to 0°C. A solution of G2-2 (626.7mg, 0.76mmol, 1.0eq.) in tetrahydrofuran (8mL) was slowly added dropwise. 0 ℃ reaction 4h. After the reaction was complete, quench the reaction with 1M NaOH (2 mL), dilute the reaction solution with ether (10 mL), add anhydrous sodium sulfate (4 g), and stir at room temperature for 2 h. The solid was filtered off, dried with anhydrous potassium carbonate, the solvent was distilled off, and the crude product was recrystallized from ether/n-hexane to obtain 3493.1 mg of white solid G2-349, with a yield of 84%. Mp276.1-277.7℃;[α] D 24 =-28.4(c0.34,CH 2 Cl 2 ); 1 H NMR(400MHz,CDCl 3 /TMS):δ7.71-7.25(m,36H),4.39 (s,2H),2.46(brs,4H),1.20(s,6H); 13 C NMR(101MHz,CDCl 3 /TMS):δ148.9,142.9,140.7,140.7,139.6,139.3,129.7,128.9,128.7, 127.9, 127.4, 127.2, 127.0, 126.8, 126.0, 107.7, 81.9, 62.4, 27.3; , 1072, 1007, 844, 833, 766, 745, 698; HRMS (ESI) Calcd. for C 55 H 49 N 2 O 2 + ([M+H] + ) 769.3794, Found 769.3782.
4.G2-4的合成: 4. Synthesis of G2-4:
氮气氛下,向溶有G2-3(768.9mg,1mmol,1.0eq.)的吡啶(2mL)溶液中加入二硫化碳(120μL,2mmol,2.0eq.)。将反应液升温至60℃,反应18h。反应完全后冷却到室温,向反应液中加二氯甲烷(20mL)和水(20mL),1M HCl调pH=2,分出有机相,水相二氯甲烷取三次(50mL×3),合并有机相,1MNaOH溶液洗(50mL×1),饱和氯化钠溶液洗(60mL×1),无水硫酸钠干燥,蒸出溶剂,粗产物二氯甲烷/正己烷重结晶得白色固体G2-4810mg,产率99%。Mp322.9-324.3℃;[α]D 24=-131.1(c0.339,CH2Cl2);1H NMR(400MHz,CDCl3/TMS):δ7.79-7.71(m,12H),7.55-7.28(m,24H),6.96(s,2H),4.74(s,2H),1.32(s,6H);13C NMR(101MHz,CDCl3/TMS):δ186.1,142.110,141.510,140.7,140.2,140.1,138.6,129.8,129.0,128.9,128.2,127.7,127.6,127.1,127.1,126.6,111.1,78.3,70.3,27.1;IR(KBr):3383,3055,3028,2989,2985,15189,1487,1421,1166,1099,837,765,696;HRMS(ESI)Calcd.for C56H47N3O2S+([M+H]+)811.3358,Found811.3355。 Under a nitrogen atmosphere, carbon disulfide (120 μL, 2 mmol, 2.0 eq.) was added to a solution of G2-3 (768.9 mg, 1 mmol, 1.0 eq.) in pyridine (2 mL). The temperature of the reaction solution was raised to 60° C., and the reaction was carried out for 18 hours. After the reaction is complete, cool to room temperature, add dichloromethane (20mL) and water (20mL) to the reaction solution, adjust the pH to 2 with 1M HCl, separate the organic phase, and take three times (50mL×3) of the aqueous phase dichloromethane, and combine Organic phase, washed with 1M NaOH solution (50mL×1), washed with saturated sodium chloride solution (60mL×1), dried over anhydrous sodium sulfate, evaporated the solvent, and recrystallized the crude product from dichloromethane/n-hexane to obtain white solid G2-4810mg , Yield 99%. Mp322.9-324.3℃;[α] D 24 =-131.1(c0.339,CH 2 Cl 2 ); 1 H NMR(400MHz,CDCl 3 /TMS):δ7.79-7.71(m,12H),7.55 -7.28(m,24H),6.96(s,2H),4.74(s,2H),1.32(s,6H); 13 C NMR(101MHz,CDCl 3 /TMS):δ186.1,142.110,141.510,140.7,140.2 ,140.1,138.6,129.8,129.0,128.9,128.2,127.7,127.6,127.1,127.1,126.6,111.1,78.3,70.3,27.1;IR(KBr):3383,3055,3028,2989,2985,148189, 1421, 1166, 1099, 837, 765, 696; HRMS (ESI) Calcd. for C 56 H 47 N 3 O 2 S + ([M+H] + ) 811.3358, Found 811.3355.
4.手性胍合成: 4. Chiral guanidine synthesis:
1)手性胍6的合成: 1) Synthesis of chiral guanidine 6:
氮气氛下,向50mL反应瓶中依次加入无水碳酸钾(276.4mg,2.0mmol,4.0eq.)、氯化亚铜(104.0mg,1.05mmol,2.1eq.)、四氢呋喃(5mL)、G2-4(405.5mg,0.5mmol,1.0eq.),室温搅拌10min后,加入对甲基苄胺(84.8mg,0.7mmol,1.4eq.),升温至40℃,反应15h。反应完全后冷却到室温,向反应液中加饱和氯化铵溶液(30mL),1M HCl调pH=4,二氯甲烷萃取三次(40mL×3),合并有机相过滤,滤液饱和氯化钠溶液洗(20mL×1),无水硫酸钠干燥,蒸出溶剂,粗产物柱层析(二氯甲烷/甲醇=20/1)得白色固体。将所得固体溶于二氯甲烷(40mL)中,加入2M NaOH溶液(8mL),室温搅拌2h,水相二氯甲 烷萃取(5mL×2),合并有机相,饱和氯化钠溶液洗(10mL×1),无水碳酸钾干燥,蒸出溶剂得白色固体6332.9mg,产率85%。 Under nitrogen atmosphere, add anhydrous potassium carbonate (276.4mg, 2.0mmol, 4.0eq.), cuprous chloride (104.0mg, 1.05mmol, 2.1eq.), tetrahydrofuran (5mL), G2- 4 (405.5mg, 0.5mmol, 1.0eq.), stirred at room temperature for 10min, added p-methylbenzylamine (84.8mg, 0.7mmol, 1.4eq.), heated to 40°C, and reacted for 15h. After the reaction is complete, cool to room temperature, add saturated ammonium chloride solution (30mL) to the reaction solution, adjust the pH to 4 with 1M HCl, extract three times with dichloromethane (40mL×3), combine the organic phases and filter, and the filtrate is saturated with sodium chloride solution Wash (20mL×1), dry over anhydrous sodium sulfate, evaporate the solvent, and column chromatography (dichloromethane/methanol=20/1) of the crude product gives a white solid. Dissolve the obtained solid in dichloromethane (40mL), add 2M NaOH solution (8mL), stir at room temperature for 2h, extract the aqueous phase with dichloromethane (5mL×2), combine the organic phases, wash with saturated sodium chloride solution (10mL ×1), dried with anhydrous potassium carbonate, and distilled off the solvent to obtain 6332.9 mg of white solid, with a yield of 85%.
2)手性胍7的合成: 2) Synthesis of chiral guanidine 7:
氮气氛下,向50mL反应瓶中依次加入无水碳酸钾(55.3mg,10.4mmol,4.0eq.)、氯化亚铜(20.8mg,0.21mmol,2.1eq.)、四氢呋喃(1mL)、G2-4(81.1mg,0.1mmol,1.0eq.)。室温搅拌10min后,加入L-叔亮氨醇(23.4mg,0.2mmol,2.0eq.),升温至40℃,反应48h。反应完全后冷却到室温,向反应液中加饱和氯化铵溶液(15mL),1M HCl调pH=4,二氯甲烷取三次(20mL×3),合并有机相过滤,滤液饱和氯化钠溶液洗(10mL×1),无水硫酸钠干燥,蒸出溶剂,粗产物柱层析(二氯甲烷/甲醇=50/1)白色固体。将所得固体溶于二氯甲烷(25mL)中,加入2M NaOH溶液(5mL),室温搅拌2h,水相二氯甲烷萃取(5mL×2),合并有机相,饱和氯化钠溶液洗(5mL×1),无水碳酸钾干燥,蒸出溶剂得白色固体763.5mg,产率71%。 Under nitrogen atmosphere, add anhydrous potassium carbonate (55.3mg, 10.4mmol, 4.0eq.), cuprous chloride (20.8mg, 0.21mmol, 2.1eq.), tetrahydrofuran (1mL), G2- 4 (81.1 mg, 0.1 mmol, 1.0 eq.). After stirring at room temperature for 10 min, L-tert-leucinol (23.4 mg, 0.2 mmol, 2.0 eq.) was added, and the temperature was raised to 40°C for 48 h. After the reaction is complete, cool to room temperature, add saturated ammonium chloride solution (15mL) to the reaction solution, adjust the pH to 4 with 1M HCl, take dichloromethane three times (20mL×3), combine the organic phases and filter, and the filtrate is saturated with sodium chloride solution Wash (10mL×1), dry over anhydrous sodium sulfate, evaporate the solvent, the crude product is column chromatographed (dichloromethane/methanol=50/1) as a white solid. Dissolve the obtained solid in dichloromethane (25mL), add 2M NaOH solution (5mL), stir at room temperature for 2h, extract the aqueous phase with dichloromethane (5mL×2), combine the organic phases, wash with saturated sodium chloride solution (5mL× 1), dried with anhydrous potassium carbonate, and distilled off the solvent to obtain 763.5 mg of white solid, with a yield of 71%.
实施例3: Example 3:
反应试剂与条件:a)环己酮,对甲苯磺酸,氯化锌,苯,回流,18h;b)溴苯,镁粉,四氢呋喃,回流,1.5h,产率75%(两步反应);c)二氯亚砜,三乙胺,二氯甲烷,回流,3h;d)叠氮钠,N,N-二甲基甲酰胺,80℃,72h,产率71%(两步反应);e)四氢铝锂,四氢呋喃,0℃,4h,产率84%;f)二硫化碳,吡啶,60℃,产率83%;g)对甲基苄胺,氯化亚铜,碳酸钾,四氢呋喃,40℃,12h,产率62%。 Reagents and conditions: a) cyclohexanone, p-toluenesulfonic acid, zinc chloride, benzene, reflux, 18h; b) bromobenzene, magnesium powder, tetrahydrofuran, reflux, 1.5h, yield 75% (two-step reaction) ; c) thionyl chloride, triethylamine, dichloromethane, reflux, 3h; d) sodium azide, N,N-dimethylformamide, 80℃, 72h, yield 71% (two-step reaction) ; e) lithium aluminum tetrahydride, tetrahydrofuran, 0 ℃, 4h, yield 84%; f) carbon disulfide, pyridine, 60 ℃, yield 83%; g) p-methylbenzylamine, cuprous chloride, potassium carbonate, Tetrahydrofuran, 40°C, 12h, yield 62%.
1.G3-1的合成: 1. Synthesis of G3-1:
氮气氛下,向250mL三口烧瓶中依次加入无水苯(200mL)、L-酒石酸二乙酯(11.5g,56mmol)、环己酮(8.2g,8.7mL,84mmol,1.5eq.)、对甲苯磺酸(0.35g)、二氯化锌(0.35g)。升温至回流,反应18h。冷却到室温,加入NaHCO3(1.4g)继续搅拌30min。加入水(100mL),分出有机相,水相乙酸乙酯萃取两次(100mL×2),合并有机相,水洗(100mL×1),饱和氯化钠水溶液洗(100 mL×1),无水硫酸钠干燥,蒸出溶剂得缩酮为黄色油状物16g,产率100%。 Under nitrogen atmosphere, add anhydrous benzene (200mL), L-diethyl tartrate (11.5g, 56mmol), cyclohexanone (8.2g, 8.7mL, 84mmol, 1.5eq.), p-toluene Sulfonic acid (0.35g), zinc dichloride (0.35g). The temperature was raised to reflux, and the reaction was carried out for 18h. After cooling to room temperature, NaHCO 3 (1.4 g) was added and stirring was continued for 30 min. Add water (100mL), separate the organic phase, extract the aqueous phase with ethyl acetate twice (100mL×2), combine the organic phases, wash with water (100mL×1), wash with saturated sodium chloride aqueous solution (100mL×1), no Dry over sodium sulfate and distill off the solvent to obtain 16 g of the ketal as a yellow oil, with a yield of 100%.
氮气氛下,将装有新制格式试剂{由溴苯(12.6g,80mmol,5.0eq.),镁粉(2.1g,88mmol,5.5eq.)和四氢呋喃(60mL)制得}的250mL三口烧瓶置于冰水浴中。缓慢滴加溶有上述所得缩酮(4.6g,216mmol,1.0eq.)的四氢呋喃(4mL)溶液。加完室温反应过夜。加入饱和氯化铵水溶液(100mL)淬灭反应。分出有机相,水相乙酸乙酯萃取三次(100mL×3),合并有机相,水洗(80mL×1),饱和氯化钠水溶液洗(100mL×1),无水硫酸钠干燥,蒸出溶剂乙酸乙酯/石油醚重结晶得白色固体G3-16.1g,产率75%。1H NMR(400MHz,CDCl3/TMS):δ7.57-7.47(m,4H),7.39-7.21(m,16H),4.55(s,2H),3.73(brs,2H),1.50-1.31(m,4H),1.31-1.07(m,6H)。 Under nitrogen atmosphere, put a 250mL three-necked flask containing newly prepared Grignard reagent {made from bromobenzene (12.6g, 80mmol, 5.0eq.), magnesium powder (2.1g, 88mmol, 5.5eq.) and tetrahydrofuran (60mL)} into in an ice water bath. A solution of tetrahydrofuran (4 mL) in which the above obtained ketal (4.6 g, 216 mmol, 1.0 eq.) was dissolved was slowly added dropwise. The reaction was completed overnight at room temperature. The reaction was quenched by adding saturated aqueous ammonium chloride (100 mL). Separate the organic phase, extract the aqueous phase with ethyl acetate three times (100mL×3), combine the organic phases, wash with water (80mL×1), wash with saturated sodium chloride aqueous solution (100mL×1), dry over anhydrous sodium sulfate, and evaporate the solvent Ethyl acetate/petroleum ether was recrystallized to obtain white solid G3-16.1g with a yield of 75%. 1 H NMR (400MHz, CDCl 3 /TMS): δ7.57-7.47 (m, 4H), 7.39-7.21 (m, 16H), 4.55 (s, 2H), 3.73 (brs, 2H), 1.50-1.31 ( m, 4H), 1.31-1.07 (m, 6H).
2.G3-2的合成: 2. Synthesis of G3-2:
氮气氛下,向溶有G2-1(1.52g,3mmol,1.0eq.)的二氯甲烷(20mL)溶液的100mL三口烧瓶中,滴加氯化亚砜(1.07g,9mmol,3.0eq.)。将反应液升温至回流,缓慢滴加溶有三乙胺(1.21g,18mmol,6eq.)的二氯甲烷(20mL)溶液,TLC检测反应。反应完全后冷却到室温,蒸出溶剂得黑褐色固体。加入N,N-二甲基甲酰胺(12mL),叠氮化钠(0.78g,12mmol,4.0eq.)。加入将反应液升温至80℃,反应72h。反应完全后冷却到室温,将反应液倾入冷的水(100m)中,分出有机相,水相乙醚萃取三次(100mL×1,60mL×2),合并有机相,水洗(50mL×3),无水硫酸钠干燥,蒸出溶剂,粗产物柱层析(石油醚/乙酸乙酯=50/1)得白色固体G3-21.19g,产率71%。Mp162.1-163.7℃;1H NMR(400MHz,CDCl3)δ7.40-7.18(m,20H),4.90(s,2H),1.49-1.39(m,4H),1.30-1.22(m,6H);13C NMR(101MHz,CDCl3)δ142.0,140.2,129.6,128.3,128.1,127.8,127.7,127.6,110.7,80.0,73.2,36.7,25.0,24.1;IR(KBr):3446,3060,2929,2853,2120,1376,1366,1267,1107,756,737,698;HRMS(ESI)Calcd.for C34H32N6O2Na+([M+Na]+)579.2484,Found579.2473。 Under a nitrogen atmosphere, add thionyl chloride (1.07g, 9mmol, 3.0eq.) dropwise to a 100mL three-necked flask containing a solution of G2-1 (1.52g, 3mmol, 1.0eq.) in dichloromethane (20mL) . The temperature of the reaction solution was raised to reflux, and a solution of triethylamine (1.21g, 18mmol, 6eq.) in dichloromethane (20mL) was slowly added dropwise, and the reaction was detected by TLC. After the reaction was complete, it was cooled to room temperature, and the solvent was distilled off to obtain a dark brown solid. Add N,N-dimethylformamide (12 mL), sodium azide (0.78 g, 12 mmol, 4.0 eq.). After adding, the temperature of the reaction solution was raised to 80°C, and the reaction was carried out for 72h. After the reaction is complete, cool to room temperature, pour the reaction solution into cold water (100m), separate the organic phase, extract the aqueous phase with ether three times (100mL×1, 60mL×2), combine the organic phases, wash with water (50mL×3) , dried over anhydrous sodium sulfate, the solvent was distilled off, and the crude product was subjected to column chromatography (petroleum ether/ethyl acetate=50/1) to obtain a white solid G3-21.19g with a yield of 71%. Mp162.1-163.7℃; 1 H NMR (400MHz, CDCl 3 ) δ7.40-7.18(m,20H),4.90(s,2H),1.49-1.39(m,4H),1.30-1.22(m,6H ); 13 C NMR (101MHz, CDCl 3 ) δ142.0, 140.2, 129.6, 128.3, 128.1, 127.8, 127.7, 127.6, 110.7, 80.0, 73.2, 36.7, 25.0, 24.1; IR(KBr): 3446, 3060, 2929, 2853, 2120, 1376, 1366, 1267, 1107, 756, 737, 698; HRMS (ESI) Calcd. for C 34 H 32 N 6 O 2 Na + ([M+Na] + ) 579.2484, Found 579.2473.
3.G3-3的合成: 3. Synthesis of G3-3:
氮气氛下,将LiAlH4(455.4mg,12mmol,6.0eq.)悬浮于四氢呋喃(15mL)中,冷却到0℃。缓慢滴加溶有G3-2(1113.7mg,2mmol,1.0eq.)的四氢呋喃(15mL)溶液。0℃反应4h。反应完全后,1M NaOH(8mL)淬灭反应,反应液加乙醚(15mL)稀释后,加入无水硫酸钠(8g),室温搅拌2h。滤除固体,无水碳酸钾干燥,蒸出溶剂,粗产物柱层析(二氯甲烷/甲醇=20/1)得白色固体G3-3851.1mg,产率84%。Mp228.4-231.7℃;1H NMR(400MHz,CDCl3)δ 7.55-7.50(m,4H),7.35-7.29(m,6H),7.24-7.10(m,10H),4.20(s,2H),2.21(brs,4H),1.51-1.36(m,4H),1.28-1.22(m,6H);IR(KBr):3359,2942,2858,1493,1367,1352,1122,767,740,704;HRMS(ESI)Calcd.for C34H37N2O2 +([M+H]+)505.2855,Found505.2863。 Under nitrogen atmosphere, LiAlH 4 (455.4mg, 12mmol, 6.0eq.) was suspended in tetrahydrofuran (15mL) and cooled to 0°C. A solution of G3-2 (1113.7mg, 2mmol, 1.0eq.) in tetrahydrofuran (15mL) was slowly added dropwise. 0 ℃ reaction 4h. After the reaction was complete, the reaction was quenched with 1M NaOH (8 mL), and the reaction solution was diluted with ether (15 mL), then anhydrous sodium sulfate (8 g) was added, and stirred at room temperature for 2 h. The solid was filtered off, dried with anhydrous potassium carbonate, and the solvent was distilled off. The crude product was subjected to column chromatography (dichloromethane/methanol=20/1) to obtain 1.1 mg of white solid G3-3851, with a yield of 84%. Mp228.4-231.7℃; 1 H NMR (400MHz, CDCl 3 )δ 7.55-7.50(m,4H),7.35-7.29(m,6H),7.24-7.10(m,10H),4.20(s,2H) ,2.21(brs,4H),1.51-1.36(m,4H),1.28-1.22(m,6H);IR(KBr):3359,2942,2858,1493,1367,1352,1122,767,740,704;HRMS(ESI ) Calcd. for C 34 H 37 N 2 O 2 + ([M+H] + ) 505.2855, Found 505.2863.
4.G3-4的合成: 4. Synthesis of G3-4:
氮气氛下,向溶有G3-3(850mg,1.68mmol,1.0eq.)的吡啶(2mL)溶液中加入二硫化碳(204μL,3.37mmol,2.0eq.)。将反应液升温至60℃,反应20h。反应完全后冷却到室温,向反应液中加二氯甲烷(50mL)和水(20mL),1M HCl调pH=2,分出有机相,水相二氯甲烷萃取三次(20mL×3),合并有机相,1M NaOH溶液洗(20mL×1),饱和氯化钠溶液洗(30mL×1),无水硫酸钠干燥,蒸出溶剂,粗产物柱层析(石油醚/乙酸乙酯=10/1)得白色固体G3-4762mg,产率83%。Mp258.3-261.2℃;[α]D 24=-197.5(c0.11,CH2Cl2);1H NMR(400MHz,CDCl3)δ7.60-7.57(m,4H),7.44-7.34(m,6H),7.29-7.26(m,6H),7.20-7.11(m,4H),6.87(s,2H),4.58(s,2H),1.55-1.22(m,10H);13C NMR(101MHz,CDCl3)δ185.7,143.6,139.8,129.3,128.8,128.4,128.0,127.9,127.7,111.3,77.3,70.7,36.3,24.9,23.7;IR(KBr):3378,3058,2935,1635,1447,1366,1119,755,699;HRMS(ESI)Calcd.for C35H34N2O2SNa+([M+Na]+)569.2239,Found569.2216。 Under a nitrogen atmosphere, carbon disulfide (204 μL, 3.37 mmol, 2.0 eq.) was added to a solution of G3-3 (850 mg, 1.68 mmol, 1.0 eq.) in pyridine (2 mL). The temperature of the reaction solution was raised to 60° C., and the reaction was carried out for 20 h. After the reaction is complete, cool to room temperature, add dichloromethane (50mL) and water (20mL) to the reaction solution, adjust the pH to 2 with 1M HCl, separate the organic phase, extract the aqueous phase with dichloromethane three times (20mL×3), and combine Organic phase, washed with 1M NaOH solution (20mL×1), washed with saturated sodium chloride solution (30mL×1), dried over anhydrous sodium sulfate, evaporated the solvent, crude product column chromatography (petroleum ether/ethyl acetate=10/ 1) The white solid G3-4762mg was obtained, and the yield was 83%. Mp258.3-261.2℃; [α] D 24 =-197.5(c0.11, CH 2 Cl 2 ); 1 H NMR (400MHz, CDCl 3 ) δ7.60-7.57(m, 4H), 7.44-7.34( m,6H),7.29-7.26(m,6H),7.20-7.11(m,4H),6.87(s,2H),4.58(s,2H),1.55-1.22(m,10H); 13 C NMR( 101MHz,CDCl 3 )δ185.7,143.6,139.8,129.3,128.8,128.4,128.0,127.9,127.7,111.3,77.3,70.7,36.3,24.9,23.7;IR(KBr):3378,3058,2935,4735,14 1366, 1119, 755, 699; HRMS (ESI) Calcd. for C 35 H 34 N 2 O 2 SNa + ([M+Na] + ) 569.2239, Found 569.2216.
4.手性胍20的合成: 4. Synthesis of chiral guanidine 20:
氮气氛下,向50mL反应瓶中依次加入无水碳酸钾(55.3mg,20.4mmol,4.0eq.)、氯化亚铜(20.8mg,0.21mmol,2.1eq.)、四氢呋喃(1mL)、G3-4(54.7mg,0.1mmol,1.0eq.),室温搅拌10min后,加入对甲基苄胺(18.2mg,0.15mmol,1.5eq.),升温至40℃,反应12h。反应完全后冷却到室温,向反应液中加饱和氯化铵溶液(25mL),1M HCl调pH=4,二氯甲烷萃取三次(25mL×3),合并有机相过滤,滤液饱和氯化钠溶液洗(15mL×1),无水硫酸钠干燥,蒸出溶剂,粗产物柱层析(二氯甲烷/甲醇=20/1)得白色固体。将所得固体溶于二氯甲烷(20mL)中,加入2M NaOH溶液(4mL),室温搅拌2h,水相二氯甲烷取(5mL×2),合并有机相,饱和氯化钠溶液洗(5mL×1),无水碳酸钾干燥,蒸出溶剂得白色固体2039.4mg,产率62%。 Under nitrogen atmosphere, add anhydrous potassium carbonate (55.3mg, 20.4mmol, 4.0eq.), cuprous chloride (20.8mg, 0.21mmol, 2.1eq.), tetrahydrofuran (1mL), G3- 4 (54.7mg, 0.1mmol, 1.0eq.), stirred at room temperature for 10min, added p-methylbenzylamine (18.2mg, 0.15mmol, 1.5eq.), heated to 40°C, and reacted for 12h. After the reaction is complete, cool to room temperature, add saturated ammonium chloride solution (25mL) to the reaction solution, adjust the pH to 4 with 1M HCl, extract three times with dichloromethane (25mL×3), combine the organic phases and filter, and the filtrate is saturated with sodium chloride solution Wash (15mL×1), dry over anhydrous sodium sulfate, evaporate the solvent, and column chromatography (dichloromethane/methanol=20/1) of the crude product gives a white solid. Dissolve the obtained solid in dichloromethane (20mL), add 2M NaOH solution (4mL), stir at room temperature for 2h, take the aqueous phase in dichloromethane (5mL×2), combine the organic phases, and wash with saturated sodium chloride solution (5mL×2) 1), dried with anhydrous potassium carbonate, and distilled off the solvent to obtain 2039.4 mg of white solid, with a yield of 62%.
催化应用实例 Catalytic application examples
光学活性的α-羟基-β-二羰基结构广泛存在于天然产物、医药和农药化学品分子中,也是合成一些手性化合物的关键中间体。不对称催化氧化β-二羰基化合物是获得此类结构单元最有效的方法之一。有机催化中,现仅有金鸡纳生物 碱催化β-酮酸酯不对称α-羟基化反应实现工业化,可获得较好的收率和中等的对映选择性。因此继续开发具有新型骨架结构的廉价有效的手性有机小分子催化剂具有重要的理论意义和应用价值。本专利制备了一系列基于酒石酸骨架的新型手性胍催化剂,并应用于β-二羰基化合物的不对称α-羟基化反应,取得几乎定量的收率和非常好的对映选择性(表3),为合成光学活性的α-羟基-β-二羰基结构提供了重要的催化方法。 The optically active α-hydroxy-β-dicarbonyl structure widely exists in natural products, pharmaceutical and agrochemical chemical molecules, and is also a key intermediate for the synthesis of some chiral compounds. Asymmetric catalytic oxidation of β-dicarbonyl compounds is one of the most effective methods to obtain such building blocks. In organic catalysis, only cinchona alkaloids catalyze the asymmetric α-hydroxylation of β-keto esters to achieve industrialization, which can obtain better yield and moderate enantioselectivity. Therefore, it is of great theoretical significance and application value to continue to develop cheap and effective chiral organic small molecule catalysts with novel framework structures. This patent prepared a series of new chiral guanidine catalysts based on tartaric acid skeleton, and applied them to the asymmetric α-hydroxylation reaction of β-dicarbonyl compounds, achieving almost quantitative yield and very good enantioselectivity (Table 3 ), providing an important catalytic method for the synthesis of optically active α-hydroxy-β-dicarbonyl structures.
表3:氮气氛下,21(1.0eq.)、6(0.1eq.)和22(1.2eq.)于甲苯中,-78℃反应0.5~13h,石油醚与乙酸乙酯为洗脱剂,柱层析分离得到产物23。 Table 3: Under nitrogen atmosphere, 21 (1.0eq.), 6 (0.1eq.) and 22 (1.2eq.) were reacted in toluene at -78°C for 0.5~13h, petroleum ether and ethyl acetate were used as eluents, The product 23 was isolated by column chromatography.
考察β-酮酸酯不对称α-羟基化反应时,酯基基团的大小对反应的对映选择性有很大的影响(entries1-5)。β-酮酸甲酯给出非常好的结果93%ee(entry1)。随着β-酮酸酯酯基基团的变大,反应活性和对映选择性都有所下降。β-酮酸叔 丁酯13h反应完全,以96%的产率,86%的ee值得到产物(entry4)。β-酮酸酯底物苯环的电子云密度和取代基位置影响了α-羟基化反应的对映选择性(entries6-11)。苯环5号位连有吸电子取代基(F,Cl,Br)或供电子取代基(OMe)时都能给出很好收率和对映选择性(entries6-11)。然而在4或6号位连有取代基时反应的对映选择性有所降低(entries10,11)。当反应底物为六元环的β-酮酸酯时,反应活性降低(12h反应完全),对映选择性明显下降(55%ee)。考察茚酮衍生的β-二酮的不对称α-羟基化反应时,环外酰基的大小对反应的对映选择性影响不大。乙酰基,丙酰基和丁酰基都得到了相近的产率和ee值(entries13-15)。然而当苯环5号位连有取代基时,无论是吸电子取代基(F,Cl,Br)还是供电子取代基(OMe),虽然反应的对映选择性都有所下降,但是还是得到了具有合成用途的对映选择性产物(entries16-19)。 When examining the asymmetric α-hydroxylation of β-ketoesters, the size of the ester group has a strong influence on the enantioselectivity of the reaction (entries 1-5). β-Keto acid methyl ester gave a very good result 93% ee (entry 1). Both the reactivity and enantioselectivity decreased with the enlargement of the β-ketoester ester group. The reaction of tert-butyl β-ketoacid was completed after 13 hours, and the product (entry4) was obtained with a yield of 96% and an ee value of 86%. The electron cloud density and substituent position of the benzene ring of the β-ketoester substrate affect the enantioselectivity of the α-hydroxylation reaction (entries 6–11). Electron-withdrawing substituents (F, Cl, Br) or electron-donating substituents (OMe) attached to the 5-position of the benzene ring can give good yields and enantioselectivities (entries6-11). However, the enantioselectivity of the reaction is reduced when there is a substituent at the 4 or 6 position (entries10,11). When the reaction substrate was 6-membered ring β-ketoester, the reactivity decreased (12h to complete the reaction), and the enantioselectivity decreased significantly (55% ee). When investigating the asymmetric α-hydroxylation of indanone-derived β-diketones, the size of the exocyclic acyl group has little effect on the enantioselectivity of the reaction. Acetyl, propionyl and butyryl groups were all obtained in similar yields and ee values (entries 13-15). However, when a substituent is attached to the 5-position of the benzene ring, whether it is an electron-withdrawing substituent (F, Cl, Br) or an electron-donating substituent (OMe), although the enantioselectivity of the reaction is reduced, the obtained Enantioselective products with synthetic utility were obtained (entries16-19).
催化反应产物数据 Catalytic Reaction Product Data
min,tminor=27.2min). min,t minor =27.2min).
mL/min,tmajor=15.8min,tminor=18.9min). mL/min, t major =15.8min, t minor =18.9min).
λ=254nm,30°C,0.8mL/min,tmajor=12.6min,tminor=14.3min). λ=254nm, 30°C, 0.8mL/min, t major =12.6min, t minor =14.3min).
(determined by HPLC using chiral OD-H column,hexane/2-propanol=95/5,λ=254nm,30°C,0.8mL/min,tmajor=9.9min,tminor=11.0min). (determined by HPLC using chiral OD-H column, hexane/2-propanol=95/5, λ=254nm, 30°C, 0.8mL/min, t major =9.9min, t minor =11.0min).
hexane/2-propanol=95/5,λ=254nm,30°C,0.8mL/min,tmajor=27.5min,tminor=33.6min). hexane/2-propanol=95/5, λ=254nm, 30°C, 0.8mL/min, t major =27.5min, t minor =33.6min).
80.5,53.6,39.1(d,J=2.0Hz);IR(KBr):3398,1752,1719,1205,1182,798,656cm-1;HRMS(ESI)Calcd.for C11H8O4F([M-H]-)223.0407,Found223.0411;Enantiomeric excess was determined to be91%(determined by HPLC using chiral OD-H column,hexane/2-propanol=95/5,λ=254nm,30°C,0.8mL/min,tmajor=23.3min,tminor=29.7min). 80.5,53.6,39.1(d,J=2.0Hz);IR(KBr):3398,1752,1719,1205,1182,798,656cm -1 ;HRMS(ESI)Calcd.for C 11 H 8 O 4 F([ MH] - )223.0407,Found223.0411; Enantiomeric excess was determined to be91%(determined by HPLC using chiral OD-H column, hexane/2-propanol=95/5,λ=254nm,30°C,0.8mL/min ,t major =23.3min,t minor =29.7min).
24.3min,tminor=30.9min). 24.3min, t minor =30.9min).
31.3min). 31.3min).
856,657cm-1;HRMS(ESI)Calcd.for C12H12O5Na([M+Na]+)259.0582,Found259.0572;Enantiomeric excess was determined to be91%(determined by HPLC using chiral OD-H column,hexane/2-propanol=9/1,λ=254nm,30°C,0.8mL/min,tmajor=20.5min,tminor=24.6min). 856,657cm -1 ;HRMS(ESI)Calcd.for C 12 H 12 O 5 Na([M+Na] + )259.0582,Found259.0572;Enantiomeric excess was determined to be91%(determined by HPLC using chiral OD-H column , hexane/2-propanol=9/1, λ=254nm, 30°C, 0.8mL/min, t major =20.5min, t minor =24.6min).
53.4,38.2,17.8.IR(KBr):3423,1749,1714,1260,1200,1179,769,677cm-1;HRMS(ESI)Calcd.for C12H12O4Na([M+Na]+)243.0633,Found243.0640;Enantiomeric excess was determined to be80%(determined by HPLC using chiral OD-H column,hexane/2-propanol=95/5,λ=254nm,30°C,0.8mL/min,tmajor=19.1min,tminor=22.2min). 53.4,38.2,17.8.IR(KBr):3423,1749,1714,1260,1200,1179,769,677cm -1 ; HRMS(ESI) Calcd.for C 12 H 12 O 4 Na([M+Na] + ) 243.0633, Found243.0640; Enantiomeric excess was determined to be80%(determined by HPLC using chiral OD-H column, hexane/2-propanol=95/5, λ=254nm, 30°C, 0.8mL/min, t major = 19.1min, t minor =22.2min).
tmajor=19.9min,tminor=23.9min). t major =19.9min,t minor =23.9min).
mL/min,tmajor=16.1min,tminor=18.2min). mL/min, t major =16.1min, t minor =18.2min).
27.3min). 27.3min).
39.0,29.8,7.5;IR(KBr):3407,1724,1703,1130,1109,781,735,667cm-1;HRMS(ESI)Calcd.for C12H12O3Na([M+Na]+)227.0684,Found227.0689;Enantiomeric excess was determined to be88%(determined by HPLC using chiral AS-H column,hexane/2-propanol=8/2,λ=254nm,30°C,0.7mL/min,tminor=11.0min,tmajor=19.8min). 39.0,29.8,7.5;IR(KBr):3407,1724,1703,1130,1109,781,735,667cm -1 ;HRMS(ESI) Calcd.for C 12 H 12 O 3 Na([M+Na] + )227.0684, Found227.0689;Enantiomeric excess was determined to be88%(determined by HPLC using chiral AS-H column, hexane/2-propanol=8/2,λ=254nm,30°C,0.7mL/min,t minor =11.0min ,t major =19.8min).
16.9,13.4;IR(Neat):3427,1727,1704,1124,1064,733cm-1;HRMS(ESI)Calcd.for C13H14O3Na([M+Na]+)241.0841,Found241.0838;Enantiomeric excess was determined to be86%(determined by HPLC using chiral AS-H column,hexane/2-propanol=8/2,λ=254nm,30°C,0.7mL/min,tminor=11.7min,tmajor=20.3min). 16.9,13.4;IR(Neat):3427,1727,1704,1124,1064,733cm -1 ;HRMS(ESI)Calcd.for C 13 H 14 O 3 Na([M+Na] + )241.0841,Found241.0838 ;Enantiomeric excess was determined to be86%(determined by HPLC using chiral AS-H column, hexane/2-propanol=8/2,λ=254nm,30°C,0.7mL/min,t minor =11.7min,t major =20.3min).
1699,1255,1128,624cm-1;HRMS(ESI)Calcd.for C11H9O3FNa([M+Na]+)231.0433,Found231.0437;Enantiomeric excess was determined to be79%(determined by HPLC using chiral AS-H column,hexane/2-propanol=8/2,λ=254nm,30°C,0.7mL/min,tminor=13.0min,tmajor=29.0min). 1699,1255,1128,624cm -1 ;HRMS(ESI)Calcd.for C 11 H 9 O 3 FNa([M+Na] + )231.0433,Found231.0437;Enantiomeric excess was determined to be79%(determined by HPLC using chiral AS-H column, hexane/2-propanol=8/2, λ=254nm, 30°C, 0.7mL/min, t minor =13.0min, t major =29.0min).
min). min).
excess was determined to be81%(determined by HPLC using chiral AS-H column,hexane/2-propanol=8/2,λ=254nm,30°C,0.7mL/min,tminor=13.3min,tmajor=28.3min). Excess was determined to be81%(determined by HPLC using chiral AS-H column, hexane/2-propanol=8/2, λ=254nm, 30°C, 0.7mL/min, t minor =13.3min, t major =28.3 min).
243.0633,Found243.0629;Enantiomeric excess was determined to be80%(determined by HPLC using chiral AS-H column,hexane/2-propanol=7/3,λ=254nm,30°C,0.4mL/min,tminor=14.7min,tmajor=31.1min)。 243.0633, Found243.0629; Enantiomeric excess was determined to be80% (determined by HPLC using chiral AS-H column, hexane/2-propanol=7/3, λ=254nm, 30°C, 0.4mL/min, t minor = 14.7min, t major =31.1min).
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310218970.4A CN103272638B (en) | 2013-06-04 | 2013-06-04 | Chiral guanidine catalyst based on tartaric acid skeleton and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310218970.4A CN103272638B (en) | 2013-06-04 | 2013-06-04 | Chiral guanidine catalyst based on tartaric acid skeleton and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103272638A CN103272638A (en) | 2013-09-04 |
CN103272638B true CN103272638B (en) | 2015-04-22 |
Family
ID=49055318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310218970.4A Expired - Fee Related CN103272638B (en) | 2013-06-04 | 2013-06-04 | Chiral guanidine catalyst based on tartaric acid skeleton and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103272638B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107721969B (en) * | 2017-11-08 | 2020-02-11 | 天津狄克特科技有限公司 | Preparation method of chiral catalyst ligand TADDOLs in asymmetric synthesis |
CN108440534B (en) * | 2018-04-04 | 2021-05-28 | 南开大学 | Efficient synthesis of β-chiral bicyclic or polycyclic imidazole derivatives |
CN112645839A (en) * | 2020-12-23 | 2021-04-13 | 安徽泽升科技有限公司 | Bilateral asymmetric substituent substituted tartaric acid skeleton compound and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102658199A (en) * | 2012-05-14 | 2012-09-12 | 惠州市莱佛士制药技术有限公司 | Novel asymmetric phase-transfer catalyst pentaazabicyclo and preparation method thereof |
CN102718768A (en) * | 2012-06-26 | 2012-10-10 | 惠州市莱佛士制药技术有限公司 | Chiral five-membered bicyclic guanidine compound, preparation method and application thereof |
-
2013
- 2013-06-04 CN CN201310218970.4A patent/CN103272638B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102658199A (en) * | 2012-05-14 | 2012-09-12 | 惠州市莱佛士制药技术有限公司 | Novel asymmetric phase-transfer catalyst pentaazabicyclo and preparation method thereof |
CN102718768A (en) * | 2012-06-26 | 2012-10-10 | 惠州市莱佛士制药技术有限公司 | Chiral five-membered bicyclic guanidine compound, preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
Enantioselective Claisen Rearrangements with a Hydrogen-Bond Donor Catalyst;Christopher Uyeda et al;《J. AM. CHEM. SOC.》;20080625;第130卷(第29期);9228-9229 * |
Also Published As
Publication number | Publication date |
---|---|
CN103272638A (en) | 2013-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106748771A (en) | A kind of preparation method of 6 fluoroalkyl ketone | |
WO2017012478A1 (en) | Functionalized cyanosilane and synthesis method and use thereof | |
CN103272638B (en) | Chiral guanidine catalyst based on tartaric acid skeleton and its preparation method and application | |
CN106748927B (en) | A kind of preparation method of thio-ether type compounds and products thereof | |
CN115784906A (en) | Method for preparing triarylmethane derivative through high-selectivity Friedel-crafts arylation reaction | |
CN104744394A (en) | Method for asymmetrically synthesizing chiral quaternary carbon compound containing trifluoromethyl | |
CN103787855B (en) | The novel method of asymmetry catalysis synthesis (S)-aryl turmerone | |
CN103467354B (en) | Method for preparing diindolyl methane derivatives | |
CN110950793A (en) | Preparation method of chiral diaryl indole methane compound | |
CN112457276B (en) | Method for synthesizing butylphthalide | |
Pan et al. | Nickel-catalyzed cross-coupling of β-carbonyl alkenyl pivalates with arylzinc chlorides | |
CN105131044A (en) | Trinuclear n-heterocyclic carbene-palladium compound, synthetic method and application | |
CN101220012B (en) | A method for synthesizing multiple substituted 4-fluoro-2(5H)-furanones | |
CN114751800B (en) | A kind of synthetic method of 5-sulfonylpenta-2,3-dienenitrile compound | |
CN108409764B (en) | A kind of organic photosensitizer that synergistically catalyzes the formation of C-X bonds with metallic nickel and its synthesis method | |
CN110642831B (en) | A kind of method for fluoroalkylation of aromatic hydrocarbon or heteroaromatic hydrocarbon under the induction of acetone | |
CN100588656C (en) | Pincer Bisimidazoline Palladium Compounds and Their Applications in Suzuki Reaction | |
CN109320538B (en) | Synthesis method of 3-bromo-5-aryl-2- (trimethylsilyl) -1- (N, N-dimethyl sulfonamide) pyrrole | |
Rajendran et al. | A domino green synthesis of bis (indolyl) methanes catalyzed by ionic liquid [Et3NH][HSO4] | |
CN115819207B (en) | Method for synthesizing 1, 1-disubstituted diene by nickel catalysis | |
CN108821995A (en) | Chiral tetrahedron-type metal cluster, metal composite and its preparation method and application | |
CN114605273B (en) | Method for synthesizing arylaminophenol compound by palladium-catalyzed CO-participated 1, 4-eneyne aromatization reaction | |
CN102603645A (en) | Method for synthetizing fenflumizole | |
CN108191736A (en) | A kind of 2,3- disubstituted indoles analog derivative and preparation method thereof | |
CN112110888B (en) | Cyano-containing chroman-4-ones and synthesis method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 Termination date: 20180604 |